Clinical Trials Directory

Trials / Unknown

UnknownNCT04380064

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Tractional Retinal Detachment: a Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Rush Eye Associates · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Subject/Participant Groups: Study Group: Subjects undergo internal limiting membrane (ILM) peeling during vitrectomy for the indication of tractional retinal detachment Control Group: Subjects do not undergo ILM peeling during vitrectomy for the indication of tractional retinal detachment

Detailed description

Hypothesis: Subjects undergoing ILM peeling during vitrectomy will have lower central macular thickness on OCT, fewer postoperative epiretinal membranes, and thereby better final visual acuity to control subjects Randomization: Subjects will be randomized according to a coin toss during PPV, once Grade 2 or Grade 3 vitreoretinal adhesion has been determined: heads undergo ILM peeling, while tails do not. Number of Subjects: With study power of 80%, a significance level of 0.05, a sample size of 60 patients for each group was calculated.

Conditions

Interventions

TypeNameDescription
PROCEDUREILM PeelingILM peeling performed during primary PPV for PDR
PROCEDURENo ILM PeelingILM peeling not performed during primary PPV for PDR

Timeline

Start date
2020-05-01
Primary completion
2025-02-01
Completion
2025-02-01
First posted
2020-05-08
Last updated
2023-11-18

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04380064. Inclusion in this directory is not an endorsement.